Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Neoleukin Therapeutics, Inc. (NLTX)

0.6888   -0.051 (-6.92%) 09-24 16:03
Open: 0.717 Pre. Close: 0.74
High: 0.7525 Low: 0.6759
Volume: 179,741 Market Cap: 29(M)
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.76 - 0.76 0.76 - 0.77
Low: 0.66 - 0.67 0.67 - 0.68
Close: 0.68 - 0.69 0.69 - 0.7

Technical analysis

as of: 2022-09-23 4:26:12 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.16     One year: 1.4
Support: Support1: 0.67    Support2: 0.56
Resistance: Resistance1: 0.99    Resistance2: 1.2
Pivot: 0.95
Moving Average: MA(5): 0.82     MA(20): 0.97
MA(100): 1.04     MA(250): 2.83
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 4.2     %D(3): 8.7
RSI: RSI(14): 22.9
52-week: High: 8.01  Low: 0.67
Average Vol(K): 3-Month: 261 (K)  10-Days: 173 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ NLTX ] has closed below the lower bollinger band by 7.8%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 67.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Headline News

Mon, 12 Sep 2022
Is Neoleukin Therapeutics Inc (NLTX) a Stock to Watch After Gaining 3.96% This Week? - InvestorsObserver

Wed, 10 Aug 2022
Neoleukin Therapeutics, Inc. (NLTX) CEO Jonathan Drachman on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha

Wed, 03 Aug 2022
Neoleukin Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference - GlobeNewswire

Wed, 27 Jul 2022
Having purchased US$934k worth of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) stock, the recent 13% pullback is not what insiders may have expected - Simply Wall St

Fri, 03 Jun 2022
Is Neoleukin Therapeutics (NASDAQ:NLTX) In A Good Position To Deliver On Growth Plans? - Simply Wall St

Mon, 09 May 2022
Neoleukin Therapeutics Announces First Quarter 2022 Financial Results and Corporate Update - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 42 (M)
Shares Float 24 (M)
% Held by Insiders 21.4 (%)
% Held by Institutions 61.3 (%)
Shares Short 1,030 (K)
Shares Short P.Month 2,230 (K)

Stock Financials

EPS -1.06
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.65
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -21.9
Return on Equity (ttm) -39.6
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.41
Qtrly Earnings Growth 0
Operating Cash Flow -48 (M)
Levered Free Cash Flow -27 (M)

Stock Valuations

PE Ratio -0.66
PEG Ratio -0.1
Price to Book value 0.18
Price to Sales 0
Price to Cash Flow -0.61

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.